Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.
about
Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.PTEN inhibits BMI1 function independently of its phosphatase activityCharacterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcriptionSolution NMR structure of the ARID domain of human AT-rich interactive domain-containing protein 3A: A human cancer protein interaction network targetNicotine-mediated signals modulate cell death and survival of T lymphocytes.Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma.Serum-nutrient starvation induces cell death mediated by Bax and Puma that is counteracted by p21 and unmasked by Bcl-x(L) inhibition.The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1.Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer.Communication routes in ARID domains between distal residues in helix 5 and the DNA-binding loops.The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.Arid3b Is Critical for B Lymphocyte DevelopmentTargeting the PI3K-Akt pathway in kidney cancer.Interferon-α signaling promotes embryonic HSC maturation.The Bright Side of Hematopoiesis: Regulatory Roles of ARID3a/Bright in Human and Mouse Hematopoiesis.The regulatory roles of phosphatases in cancer.Phosphatidylinositol 3'-kinase, mTOR, and glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cellsRepressors of reprogramming.Combating trastuzumab resistance by targeting thioredoxin-1/PTEN interaction.Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy.Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.Construction of human activity-based phosphorylation networks.Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells.Loss of Bright/ARID3a function promotes developmental plasticity.Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
P2860
Q24310569-E6DFF3AB-92BA-454F-80F3-C590DEE49C6DQ24315949-9C3E1822-76CA-4C12-B759-712FCBC0BF99Q24338860-705F630F-141A-4EA8-A205-BA1FA006E0F1Q27661470-480272A7-0409-4000-AAC3-77EF2256C8F1Q33620835-73AEC5FC-52B4-4BF7-8207-1500C235D38CQ33716011-EB4E299C-AE38-4513-8612-82857337AAF8Q33742809-1BA83272-E46E-43E9-A041-972F54B055CEQ34009416-2E5D1A60-D6F8-4BAD-AB8B-566664715673Q34742288-18CE9422-C2BE-461E-980C-20DFCDA21E70Q34742340-BF18CEDF-7BDA-4A9C-BFE1-356257C90D5CQ34756265-75D94121-2416-45FE-BEEB-488674CAA7E2Q35238111-97455F1D-27EE-4C04-85FF-ABA2DDD866E0Q35490321-D0131290-5D15-42BF-9A01-E6A391794694Q36107137-736E566A-064A-4383-97F1-A80F25669862Q36842782-71E96524-E8AB-4CE7-9E28-B25D741F34CEQ37097100-81408EBE-9421-4757-9921-1DFAC918B601Q37644905-731B2CCE-464A-41CD-9435-F003969A8367Q38090432-7A0A6B2A-EDBC-4585-BDD5-E8627D5B99E9Q38427265-E3000491-481E-410E-8A3D-A65617501AC3Q38443588-B841B943-25B7-4929-A9FF-7B4E176140DCQ38812090-940F14BE-DB00-4CEE-9612-584438D341BBQ39431060-1D52AE9C-866A-415D-8C10-26340A8E65A0Q39499342-DE7350C6-0AFA-4D52-A973-BB45C504DF94Q39902586-6037807C-59C3-4AE3-AC55-5BA409C3252DQ39994850-2864AC41-43FD-4170-A11C-09F5F6BDA8A1Q40836487-9C9256A1-D75A-4517-BD9B-B6D8672A2306Q41656076-244FE7EF-643B-4022-9DFB-401EC0E06906Q41841351-20B1DB0E-666D-4280-B5E4-28CDCC782787Q42073864-757603FD-16BB-46FD-9591-98B08A734CCD
P2860
Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@ast
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@en
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@en-gb
Bright/ARID3A contributes to c ...... oglobulin heavy chain enhancer
@nl
type
label
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@ast
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@en
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@en-gb
Bright/ARID3A contributes to c ...... oglobulin heavy chain enhancer
@nl
prefLabel
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@ast
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@en
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@en-gb
Bright/ARID3A contributes to c ...... oglobulin heavy chain enhancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Attenuation of PTEN increases ...... anism of apoptosis resistance.
@en
P2093
Jaime F Modiano
Jin-Young Park
Pei-Yin Lin
Robert H Weiss
See-Hyoung Park
Shairaz Baksh
P2860
P2888
P3181
P356
10.1186/1476-4598-6-16
P407
P577
2007-02-14T00:00:00Z
P5875
P6179
1034753356